Semaglutide vs Tesamorelin
Updated July 21, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of Semaglutide and Tesamorelin (also searched as Tesamorelin vs Semaglutide) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
Semaglutide centers on metabolic, while Tesamorelin leans toward metabolic. On indexed research, Semaglutide is ahead (Semaglutide: 5 studies, Human clinical; Tesamorelin: 3, Preclinical). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •Semaglutide is strongest for metabolic; Tesamorelin for metabolic.
- •Evidence: Semaglutide Human clinical (5 studies) vs Tesamorelin Preclinical (3).
- •Check the FDA-approval status chips above before assuming a legal use pathway.
Effect profiles, overlaid
At a glance
GLP-1 Receptor Agonist | Weight Loss & Diabetes
GHRH Analog | Visceral Fat Reduction
Semaglutide vs Tesamorelin: side-by-side
| Metric | Semaglutide | Tesamorelin |
|---|---|---|
| Class | Weight Loss | GH |
| Regulatory status | FDA-approved | FDA-approved |
| Evidence grade | Human clinical | Preclinical |
| Studies indexed | 5 | 3 |
| Research level | FDA Approved | FDA Approved |
| Strongest effect | Metabolic & appetite | Metabolic & appetite |
| Healing & recovery | 1.0▲ | 1.0▲ |
| Muscle & body comp | 0.0 | 2.0▲ |
| Metabolic & appetite | 5.0▲ | 4.0 |
| Neuro & mood | 1.0▲ | 1.0▲ |
| Sleep & circadian | 0.0 | 0.0 |
| Inflammation & immune | 2.0▲ | 1.0 |
| Skin & aesthetics | 4.0▲ | 3.0 |
▲ marks the higher community effect score (0–5 perceived-effect signal, not clinical efficacy).
Mechanism & pharmacokinetics
| Property | Semaglutide | Tesamorelin |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | GHRH analog |
| Route | Subcutaneous injection (oral form also available) | Subcutaneous injection |
| Half-life | ~7 days (≈165 h) | ~26–38 min |
| Time to peak | 1–3 days | — |
| Duration of action | Weekly dosing | — |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is Semaglutide?
### Semaglutide Summary Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been investigated for its role in managing type 2 diabetes and obesity. Its efficacy in promoting weight loss and improving glycemic control has garnered significant attention in recent clinical research.
Full Semaglutide profile, mechanism & studies →What is Tesamorelin?
### Tesamorelin Summary Tesamorelin is a synthetic peptide that functions as a growth hormone-releasing hormone (GHRH) analog, primarily investigated for its potential to reduce visceral fat in individuals with HIV-associated lipodystrophy. Its role in metabolic health and body composition continues to be explored in various clinical contexts.
Full Tesamorelin profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Even | Both ~1.0/5 |
| Muscle | Tesamorelin | 2.0/5 effect signal |
| Metabolic | Semaglutide | 5.0/5 effect signal |
| Neuro | Even | Both ~1.0/5 |
| Inflammation | Semaglutide | 2.0/5 effect signal |
| Skin | Semaglutide | 4.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack Semaglutide and Tesamorelin?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
Semaglutide vs Tesamorelin: side effects
- reduced appetite22
- early satiety17
- nausea9
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
Semaglutide has 5 approved studies indexed (Human clinical), and Tesamorelin has 3 (Preclinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is Semaglutide or Tesamorelin better?
It depends on your goal. Semaglutide is strongest for metabolic; Tesamorelin for metabolic. Semaglutide has more indexed studies (5). See the goal-by-goal breakdown above.
Is Semaglutide or Tesamorelin better for weight loss?
Semaglutide shows the stronger metabolic & appetite profile (5.0/5) in community effect data — though weight-loss outcomes depend on the individual and the evidence base.
Is Semaglutide or Tesamorelin better for muscle?
Tesamorelin leads on the muscle & body-composition axis (2.0/5).
Which has more research, Semaglutide or Tesamorelin?
Semaglutide has 5 approved studies indexed (Human clinical); Tesamorelin has 3 (Preclinical). Higher counts mean more to read, not proven superiority.
Can you stack Semaglutide and Tesamorelin?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of Semaglutide vs Tesamorelin?
Semaglutide: community-reported reduced appetite, early satiety, nausea. Tesamorelin: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is Semaglutide or Tesamorelin FDA-approved?
Semaglutide is FDA-approved. Tesamorelin is FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Tesamorelin better than Semaglutide?
For metabolic, Tesamorelin has the edge; for metabolic, Semaglutide does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 21, 2026.